Bright Minds Biosciences (DRUG) Selling, General & Administrative (2020 - 2026)
Bright Minds Biosciences' Selling, General & Administrative was $286,338 in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 139.7% from $119,443 a year earlier but down 47.6% from the prior quarter.
Bright Minds Biosciences (DRUG) Selling, General & Administrative (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bright Minds Biosciences' Selling, General & Administrative was $1.28 million through Jun 30, 2026, up 216.5% year-over-year; for FY2025 (ended Sep 30, 2025), it was $561,000, up 189.0% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of -74.0% (FY2020 to FY2025).
- In earlier fiscal years, Selling, General & Administrative was $194,100 in FY2024 (-6.1%), $206,790 in FY2023 (-100.0%), $374.62 billion in FY2022 (+140.2%) and $155.97 billion in FY2021.
- Quarterly Selling, General & Administrative has moved between -$34,252 (fiscal Q4 2023) and $366.69 billion (fiscal Q4 2022) over five years.
- Compared with a year earlier, Selling, General & Administrative has increased for seven straight quarters, with growth averaging 227.5% over the last seven quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was fiscal Q1 2022 (growth of 699.1%); the worst was fiscal Q1 2023 (a decline of 72.5%).
- Per Business Quant data, DRUG's Selling, General & Administrative in the three fiscal quarters before Q3 2026 was $545,983 (Q2 2026), $252,080 (Q1 2026) and $192,090 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Bright Minds Biosciences | 387.06 Mn | 387.06 Mn | - | 286,337.69 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 286,337.69 |
| Mar 31, 2026 | 545,982.55 |
| Dec 31, 2025 | 252,080.21 |
| Sep 30, 2025 | 192,089.60 |
| Jun 30, 2025 | 119,442.70 |
| Mar 31, 2025 | 192,806.12 |
| Dec 31, 2024 | 55,526.99 |
| Sep 30, 2024 | 35,498.11 |
| Jun 30, 2024 | 59,401.51 |
| Mar 31, 2024 | 41,532.37 |
| Dec 31, 2023 | 50,856.30 |
| Sep 30, 2023 | -34,252.38 |
| Jun 30, 2023 | 90,855.96 |
| Mar 31, 2023 | 103,552.31 |
| Dec 31, 2022 | 46,183.91 |
| Sep 30, 2022 | 366.69 Bn |
| Jun 30, 2022 | 71,207.15 |
| Mar 31, 2022 | 58,374.60 |
| Dec 31, 2021 | 167,913.55 |
| Sep 30, 2021 | 156.60 Bn |
Bright Minds Biosciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();